Antiviral agents from plants and herbs: A systematic review

Antiviral Therapy

Volumn 8, Issue 2, 2003, Pages 77-90

  Martin, Karen W ^a   Ernst, Edzard ^a  

^a PENINSULA MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ALOE VERA EXTRACT; ANDROGRAPHIS PANICULATA EXTRACT; ANTIVIRUS AGENT; BUXUS SEMPERVIRENS EXTRACT; CLINACANTHUS NUTANS EXTRACT; GARLIC EXTRACT; GLYCYRRHIZA GLABRA EXTRACT; GLYCYRRHIZA OFFICINALIS EXTRACT; KANJANG; MELALEUCA ALTERNIFOLIA EXTRACT; MELISSA OFFICINALIS EXTRACT; PHYLLANTHUS AMARUS EXTRACT; PHYLLANTHUS NIRURI EXTRACT; PHYLLANTHUS URINARIA EXTRACT; SALVIA OFFICINALIS EXTRACT; SAMBUCOL; SAMBUCUS NIGRA EXTRACT; UNCLASSIFIED DRUG; URSODEOXYCHOLIC ACID; VITAMIN;

ALOE VERA; ANAPHYLAXIS; ANDROGRAPHIS PANICULATA; ANTIVIRAL ACTIVITY; BUXUS SEMPERVIRENS; CLINACANTHUS NUTANS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG ACTIVITY; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; GARLIC; GLYCYRRHIZA GLABRA; HEPATITIS B; HEPATITIS C; HERBAL MEDICINE; HERPES SIMPLEX; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERALDOSTERONISM; IN VITRO STUDY; IN VIVO STUDY; MEDICINAL PLANT; MELALEUCA ALTERNIFOLIA; MELISSA OFFICINALIS; PHYLLANTUS AMARUS; PHYLLANTUS NIRURI; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; SALVIA OFFICINALIS; SAMBUCUS NIGRA; TREATMENT OUTCOME; VIRUS INFECTION;

ANIMALS; ANTIVIRAL AGENTS; CLINICAL TRIALS; HEPATITIS B; HIV INFECTIONS; HUMANS; PHYLLANTHUS; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS, MEDICINAL; VIRUS DISEASES;

EID: 0037693046     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (71)

1. Jadad JR, Moore A, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ & McQuay HJ. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Controlled Clinical Trials 1996; 17:1-12.
2. Koytchev R, Alken RG & Dundarov S. Balm mint extract (Lo-701) for topical treatment of recurring Herpes labialis. Phytomedicine 1999; 6:225-230.
3. Unander DW, Webster GL & Blumberg BS. Usage and bioassays in Phyllanthus (Euphorbiaceae). IV. Clustering of antiviral uses and other effects. Journal of Ethnopharmacology 1995; 45:1-18.
4. Liu J, Lin H & McIntosh H. Genus Phyllanthus for chronic hepatitis B virus infection: a systematic review. Journal of Viral Hepatitis 2001; 8:358-366.
5. Calixto JB, Santos ARS, Filbo VC & Yunes RA. A review of the plants of the genus Phyllanthus: their chemistry, pharmacology and therapeutic potential. Medical Research Review 1998; 18:225-258.
6. Lee CD, Ott M, Thyagarajan SP, Shafritz DA, Burk RD & Gupta S. Phyllanthus amarus down-regulates hepatitis B virus MRNA transcription and replication. European Journal of Clinical Investigation 1996; 26:1069-1076.
7. Blumberg BS, Millman I, Venkateswaran PS & Thyagarajan SP. Hepatitis B and primary hepatocellular carcinoma: treatment of HBV carriers with Phyllanthus amarus. Vaccine 1990; 8:S86-S92.
8. Thyagarajan SP, Subramanian S, Thirunalasundari T, Venkateswaran PS & Blumberg BS. Effect of Phyllanthus amarus on chronic carriers of Hepatitis B virus. Lancet 1988; 2:764-766.
9. Thyagarajan SP, Jayaram S, Valliammai T, Madanagopalan N, Pal VG & Jayaraman K. Phyllanthus amarus and hepatitis B. Lancet 1990; 336:949-950.
10. Leelarasamee A, Trakulsomboon S, Maunwongyathi P, Somanabandhu A, Pidetcha P, Matrakool B, Lebnak T, Ridthimat W & Chandanavingyong D. Failure of Phyllanthus amarus to eradicate hepatitis B surface antigen from symptomless carriers. Lancet 1990; 335:1600-1601.
11. Thamlikitkul V, Wasuwat S & Kanchanapee P. Efficacy of Phyllanthus amarus for eradication of hepatitis B virus in chronic carriers. Journal of the Medical Association of Thailand 1991; 74:381-385.
12. Berk L, deMan RA, Schalm SW, Labadie RP & Heitjtink RA. Beneficial effects of Phyllanthus amarus for chronic hepatitis B, not confirmed. Journal of Hepatology 1991; 12:405-406.
13. Milne A, Hopkirk N, Lucas CR, Waldon J & Foo Y. Failure of New Zealand hepatitis B carriers to respond to Phyllanthus amarus. New Zealand Medical Journal 1994; 107:253.
14. Wang M, Cheng H, Li Y, Meng L, Zhao G & Mai K. Herbs of the genus Phyllanthus in the treatment of chronic hepatitis B: observations with three preparations from different geographic sites. Journal of Laboratory & Clinical Medicine 1995; 350-352.
15. Peng XC, Liu XL, Liu SC, Yang DZ, Wang WJ & Zhang HJ. [Preliminary observation of therapeutic effect of Phyllanthus herb on chronic HBsAg carriers]. Chinese Journal of Experimental Clinical Virology 1993; 7:306-307.
16. Cao WZ, Liu JQ, Cao DY, Su F & Xu SG. [Clinical study on anti-HBV activity of Phyllanthus herb from Anhui, China]. China Journal of Chinese Materia Medica 1998; 23:180-181.
17. Zhang JL, He WN & Ye P. [Clinical observations on Phyllanthus amarus for treating chronic hepatitis HBV infection]. Chinese Journal of Integrated Traditional & Western Medicine on Liver Dieases 1992; 2:8-10.
18. Huang KM. [Genus Phyllanthus for treatment of 38 cases of chronic hepatitis B]. Information on Traditional Chinese Medicine 1999; 6:32.
19. Huang ZR, Zhong JP, Zhu GL, Chen YR & Wang GQ. [Therapeutic observations on Phyllanthus amarus for hepatitis B]. Chinese Journal of Clinical Hepatology 1993; 9:108-110.
20. Zhu FM, Zhang JQ, Zhang XZ & Zhang XM. [Observation on the effect of Fujian's Phyllanthus amarus treatment of HBV infection]. Chinese Journal of Integrated Traditional & Western Medicine on Liver Disease 1992; 2:10-11.
21. Narendranathan M, Remla A, Mini PC & Satheesh P. A trial of Phyllanthus amarus in acute viral hepatitis. Tropical Gastroenterology 1999; 20:164-166.
22. Boon H & Smith M. The Botanical Pharmacy. 1999; Quarry Press Inc., Kingston, On., Canada.
23. Wobling RH & Leonhardt K. Local therapy of herpes simplex with dried extract from Melissa officinalis. Phytomedicine 1994; 1:25-31.
24. Zakay-Rones Z, Varsano N, Zlotnik M, Manor O, Regev L, Schlesinger M & Mumcuoglu M. Inhibition of several strains of influenza virus in vitro and reduction of symptoms by an elderberry extract (Sambucus nigra L) during an outbreak of influenza B Panama. Journal of Alternative & Complementary Medicine 1995; 1:361-369.
25. Thom E, Zakay-Rones Z, Wollan T & Wadstein J. Randomised study on the efficacy and safety of an oral elderberry extract in the treatment of influenza A and B virus infections. Proceedings of the 15th International Conference on Antiviral Research. Prague, Czech Republic, March 2002.
26. Madav S, Tandan SK, Lal J & Tripathi HC. Anti-inflammatory activity of andrographolide. Fitotherapia 1996; LXVII:452-458.
27. Puri A, Saxena R, Saxena RP, Saxena KC, Srivastava V & Tandonj JS. Immunostimulant agents from Andrographis panictilata. Journal of Natural Products 1993; 56:995-999.
28. Chang RS, Ding L, Chen GQ, Pan QC, Zhao ZL & Smith KM. Dehydroandrographolide succinic acid monoester as an inhibitor against the human immunodeficiency virus. Proceedings of the Society of Experimental & Biological Medicine 1991; 197:59-66.
29. Caceres DD, Hancke JL, Burgos RA & Wikman GK. Prevention of common colds with Andrographis paniculata dried extract. A pilot double blind trial. Phytomedicine 1997; 4:101-104.
30. Hancke J, Burgos R, Caceres D & Wikman G. A double-blind study with a new monodrug kan jang: decrease of symptoms and improvement in the recovery from common colds. Phytotherapy Research 1995; 9:559-562.
31. Caceres DD, Hancke JL, Burgos RA, Sandberg F & Wikman GK. Use of visual analogue scale measurements (VAS) to assess the effectiveness of standardized Andrographis paniculata extract SHA-10 in reducing the symptoms of common cold. A randomized double blind placebo study. Phytomedicine 1999; 6:217-223.
32. Melchoir J, Palm S & Wikman G. Controlled clinical study of standardised Andrographis paniculata extract in common cold - a pilot trial. Phytomedicine 1996; 3:315-318.
33. Calabrese C, Berman SH, Babish JG, Ma X, Shinto L, Dorr M, Wells K, Wenner CA & Standish LJ. A Phase I trial of andrographolide in HIV positive patients and normal volunteers. Phytotherapy Research 2000; 14:333-338.
34. Yoosook C, Panpisutchai Y, Chaichana S, Santisuk T & Reutrakul V. Evaluation of anti-HSV-2 activities of Barleria lupulina and Clinacanthus nutans. Journal of Ethnopharmacology 1999; 67:179-187.
35. Sangkitporn S, Chaiwat S, Balachandra K, Na-Ayudhaya TD, Bunjob M & Jayavasu C. Treatment of herpes zoster with Clinacanthus nutans (bi phaya yaw) extract. Journal of the Medical Association of Thailand 1995; 178:624-627.
36. Jayavasu C, Balachandra K, Sangkitporn S, Maharungraungrat A, Thavatsupa P, Bunjob M, Chavalittumrong P, Dechatiwongse Na Ayudhaya T & Sittisomwong N. Clinical trial in the treatment of genital herpes patients with Clinacanthus nutans extract. Communicable Disease Journal 1992; 18:152-161.
37. Charuwichitratana S, Wongrattanapasson N, Timpatanapong P & Bunjob M. Herpes zoster: treatment with Clinacanthus nutans cream. International Journal of Dermatology 1996; 35:665-666.
38. Vogler BK & Ernst E. Aloe vera: a systemic review of its clinical effectiveness. British Journal of General Practice. 1999; 49:823-828.
39. Syed TA, Cheema KM, Ashfaq Ahmad S & Holt AH Jr. Aloe vera extract 0.5% in hydrophilic cream versus Aloe vera gel for the management of genital herpes in males. A placebo-controlled, double-blind comparative study. Journal of the European Academy of Dermatology & Venerology 1996; 7:294-295.
40. Syed TA, Afzal M, Ashfaq Ahmad S, Holt AH, Ali Ahmad S & Ahmad SH. Management of genital herpes in men with 0.5% Aloe vera extract in hydrophilic cream: a placebo-controlled double-blind study. Journal of Dermatological Treatment 1997; 8:99-102.
41. Schnitzler P, Schon K & Reichling J. Antiviral activity of Australian tea tree oil and eucalyptus oil against herpes simplex virus in cell culture. Pharmazie 2001; 56:343-347.
42. Carson CF, Ashton L, Dry L, Smith DW & Riley TV. Melaleuca alternifolia (tea tree) oil gel (6%) for the treatment of recurrent herpes labialis. Journal of Antimicrobial Chemotherapy 2001; 48:450-451.
43. Durant J, Chantre G, Gonzalez G, Vandermander J, Halfon Ph, Rousse B, Guedon D, Rahelinirina V, Chamaret S, Montagnier L & Dellamonica P. Efficacy and safety of Buxus sempervirens L preparations (SPV30) in HIV-infected patients: a multicentre, randomized, double-blind, placebo-controlled trial. Phytomedicine 1998; 5:1-10.
44. Ankri S & Mirelman D. Antimicrobial properties of allicin from garlic. Microbes & Infection 1999; 1:125-129.
45. Weber ND, Andersen DO, North JA, Murray BK, Lawson LD & Hughes BG. In vitro virucidal effects of Allium sativum (garlic) extract and compounds. Planta Medica 1992; 58:417-423.
46. Josling P. Preventing the common cold with a garlic supplement: a double-blind, placebo-controlled survey. Advances in Therapy 2001; 18:189-193.
47. Newall CA, Anderson LA & Phillipson JD. Herbal Medicines, A Guide for Healthcare Professionals. 1996; London: Pharmaceutical Press.
48. Thom E & Wollan T. A controlled clinical study of Kanjang mixture in the treatment of uncomplicated upper respiratory tract infections. Phytotherapy Research 1997; II:207-210.
49. Saller R, Buechi S, Meyrat R & Schmidhauser C. Combined herbal preparation for topical treatment of herpes labialis. Forsch Komplementarmed Klass Naturheilkd 2001; 8:373-382.
50. Shibata S. A drug over the millennia: pharmacognosy, chemistry and pharmacology of licorice. Yakugaku Zasshi 2000; 120:849-862.
51. Pompei R, Flore O, Marccialis MA & Pani A & Loddo B. Glycyrrhizic acid inhibits virus growth and inactivates virus particles. Nature 1979; 25:689-690.
52. Crance JM, Leveque F, Biziagos E, van Cuyck-Gandre H, Jouan A & Deloince R. Studies on the mechanism of action of glycyrrhizin against hepatitis A virus replication in vitro. Antiviral Research 1994; 23:63-76.
53. Su X, Chen H, Wang L, Jiang C, Liu J, Zhao M, Ma X, Zhao Y & Han D. Clinical and laboratory observation on the effect of glycyrrhizin in acute and chronic hepatitis. Journal of Traditional Chinese Medicine 1984; 4:127-132.
54. Suzuki H, Ohta Y, Tekino T, Fujisawa K & Hirayama C. Effects of glycyrrhizin on biochemical tests in patients with chronic hepatitis. Asian Medical Journal 1983; 26:423-438.
55. Arase Y, Ikeda K, Murashima N, Chayama K, Tsubota A, Koida I, Susuki Y, Saitoh S, Kobayashi M & Kumada H. The long term efficacy of glycyrrhizin in chronic hepatitis C patients. Cancer 1997; 79:1494-1500.
56. Tsubota A, Kumada H, Arase Y, Chayama K, Saitoh S, Ikeda K, Kobayashi M, Suzuki Y & Murashima N. Combined ursodeoxycholic acid and glycyrrhizin therapy for chronic hepatitis C virus infection: a randomized controlled trial in 170 patients. European Journal of Gastroenterology & Hepatology 2002; 11:1077-1083.
57. Iino S, Tango T, Matsushima T, Toda G, Miyake K, Hino K, Kumada H, Yasuda K, Kuroki T, Hirayama C & Suzuki H. Therapeutic effects of stronger neo-minophagen C at different doses on chronic hepatitis and liver cirrhosis. Hepatology Research 2001; 19:31-40.
58. Miyake K, Tango T, Ota Y, Mitamura K, Yoshiba M, Kako M, Hayashi S, Ikeda Y, Hayashida N, Iwabuchi S, Sato Y, Tomi T, Funaki N, Hashimoto N, Umeda T, Miyazaki J, Tanaka K, Endo Y & Suzuki H. Efficacy of Stronger Neominophagen C compared between two doses administered three times a week on patients with chronic viral hepatitis. Journal of Gastroenterology & Hepatology 2002; 17:1198-1204.
59. van Rossum TGJ, Vulto AG, Hop WCJ, Brouwer JT, Niesters HGM & Schalm SW. Intravenous glycyrrhizin for the treatment of chronic hepatitis C: a double-blind, randomized, placebo-controlled Phase I/II trial. Journal of Gastroenterology & Hepatology 1999; 14:1093-1099.
60. van Rossum TGJ, Vulto AG, Hop WCJ & Schalm SW. Glycyrrhizin-induced reduction of ALT in European patients with chronic hepatitis C. American Journal of Gastroenterology 2001; 96:2432-2437.
61. Gotoh Y, Tada K, Yamada K, Minamitani M, Negishi M, Fujimaki M, Ikematsu S, Hada M, Mori K, Ito M, Shigeta S, Nakashima H, Yamamoto N & Shiokawa Y. [Administration of glycyrrhizin to patients with human immunodeficiency virus infection]. Igaku no Ayumi 1987; 140:619-620.
62. Mori K, Sakai H, Susuki S, Akutsu Y, Ishikawa M, Aihara M, Yokoyama M, Sato Y, Okaniwa S & Endo Y. [The present status in prophylaxis and treatment of HIV infected patients with haemophilia in Japan]. Japanese Journal of Clinical Pathology 1989; 37:1200-1208.
63. Barnes J, Anderson LA & Phillipson JD. St John's wort (Hypericum perforatum L): a review of its chemistry, pharmacology and clinical properties. Journal of Pharmacy & Pharmacology 2001; 53:583-600.
64. Gulick RM, McAuliffe V, Holden-Wiltse J, Crumpacker C, Liebes L, Stein DS, Meehan P, Hussey S, Forcht J & Valentine FT. Phase I studies of hypericin, the active compound of St. John's wort, as an antiretroviral agent in HIV-infected adults. Annals of Internal Medicine 1999; 130:510-514.
65. Jacobson JM, Feinman L, Liebes L, Ostrow N, Koslowski V, Tobia A, Cabana BE, Lee D-H, Sprotzler J & Prince AM. Pharmacokinetics, safety and antiviral effects of hypericin, a derivative of St John's wort plant, in patients with chronic hepatitis C virus infection. Antimicrobial Agents & Chemotherapy 2001; 45:517-524.
66. Nakano M, Kurokawa M, Hozumi T, Saito A, Ida M, Morohashi M, Namba T Kawana T & Shiraki K. Suppression of recurrent genital herpes simplex virus type 2 infection by Rhus javanica in guinea pigs. Antiviral Research 1998; 39:25-33.
67. Serkedjieva J & Ivancheva S. Antiherpes virus activity of extracts from the medicinal plant Geranium sanguineum L. Journal of Ethnopharmacology 1999; 64:59-68.
68. Kurokawa M, Basnet P, Ohsugi M, Hozumi T, Kadota S, Namba T, Kawana T & Shiraki K. Anti-herpes simplex virus activity of moronic acid purified from Rhus javanica in vitro and in vivo. Journal of Pharmacology & Experimental Therapeutics 1999; 289:72-78.
69. Nawawi A, Nakamura N, Hattori M, Kurokawa M & Shiraki K. Inhibitory effects of Indonesian medicinal plants on the infection of herpes simplex virus type 1. Phytotherapy Research 1999; 13:37-41.
70. Alche LE, Berra A, Veloso MJ & Coto CE. Treatment with meliacine, a plant derived antiviral, prevents the developement of herpetic stromal keratitis in mice. Journal of Medical Virology 2000; 61:474-480.
71. Nawawi A, Nakamura N, Meselhy MR, Hattori M, Kurokawa M, Shiraki K, Kashiwaba N & Ono M. In vivo antiviral activity of Stephania cepharantha against herpes simplex virus type-1. Phytotherapy Research 2001; 15:497-500.